Recombinant Ailuropoda melanoleuca Serine/threonine-protein kinase greatwall (MASTL), partial, refers to a genetically engineered, truncated form of the MASTL kinase derived from the giant panda (Ailuropoda melanoleuca). MASTL is a conserved mitotic kinase that regulates cell cycle progression by phosphorylating substrates like ENSA/ARPP19, which inhibit PP2A/B55 phosphatase activity . The "partial" designation indicates that this recombinant protein lacks full-length sequences, typically retaining only functional domains critical for enzymatic activity or structural studies .
Kinase-Phosphatase Interaction Studies: Truncated MASTL can model interactions with PP2A/B55 and substrates like ENSA .
Drug Discovery: MASTL inhibitors (e.g., GKI-1) could be tested against recombinant panda MASTL to assess cross-species efficacy.
DNA Damage Response Analysis: MASTL regulates recovery from DNA damage by controlling CDK1 rephosphorylation . Partial constructs may help dissect this pathway.
Sequence Divergence: Giant panda MASTL may exhibit unique residues impacting substrate binding or regulation compared to human orthologs.
Functional Redundancy: Truncated forms might lack autoinhibitory regions, altering activity profiles .
Clarify evolutionary conservation of MASTL signaling in Ursidae.
Aid in understanding species-specific adaptations in cell cycle control, given the giant panda’s unique metabolic traits .
Structural Characterization: Cryo-EM or crystallography of recombinant panda MASTL to resolve NCMR architecture.
Comparative Kinase Assays: Test activity against human ENSA/ARPP19 and PP2A/B55.
In Vivo Functional Studies: CRISPR knock-in models to assess truncated MASTL’s impact on giant panda cell cycles.
KEGG: aml:100464443
STRING: 9646.ENSAMEP00000001970
MASTL (Microtubule-associated serine/threonine kinase-like), also known as Greatwall kinase (Gwl), is a key regulator of mitosis across species. In cellular processes, MASTL functions primarily by phosphorylating α-endosulfine (ENSA) and cyclic AMP-regulated 19 kDa phosphoprotein (ARPP19). When phosphorylated, these proteins bind to and inhibit protein phosphatase 2A with B55 targeting subunit (PP2A/B55), which is the principal phosphatase that dephosphorylates substrates of CDK1 .
This inhibition pathway is critical for maintaining the phosphorylation state of mitotic proteins and ensuring proper timing and progression through mitosis. MASTL is activated during mitotic entry via CDK1-mediated phosphorylation, and its kinase activity is required for mitotic progression through this mechanism .
To study MASTL methodologically, researchers should:
Use immunoblotting with phospho-specific antibodies to detect activation status
Perform kinase activity assays with purified ENSA/ARPP19 substrates
Employ cell synchronization techniques to track MASTL activity throughout the cell cycle
Use genetic approaches (siRNA, CRISPR) to assess functional consequences of MASTL manipulation
MASTL possesses a unique structural feature that distinguishes it from typical kinases - a non-conserved insertion of approximately 550 amino acids within its activation loop, splitting the kinase domain into two parts . This non-conserved middle region (NCMR) is essential for substrate discrimination and regulation of kinase activity.
Methodologically, structural characterization of MASTL requires:
Sequence analysis to identify conserved kinase domains and the NCMR region
Hydrogen/deuterium exchange mass spectrometry (HDX-MS) to examine protein dynamics
Functional analysis of truncated constructs to determine essential regions
Comparison with MASTL orthologs across species to identify conserved features
Research has revealed that the C-lobe in full-length MASTL forms a stable structure, whereas the N-lobe is more dynamic. The NCMR and C-tail contain few localized regions with higher-order structure . Importantly, a cryptic C-lobe exists within the NCMR that appears to be critical for catalytic activity. Truncated versions of MASTL that retain this cryptic C-lobe can maintain catalytic activity but may have different substrate specificities .
The regulation of MASTL protein stability involves a complex interplay of protein-protein interactions and post-translational modifications. Research has identified E6AP (encoded by the UBE3A gene) as a key ubiquitin ligase that regulates MASTL protein levels .
To methodologically investigate MASTL stability:
Assess protein half-life using cycloheximide chase assays with and without E6AP manipulation
Perform co-immunoprecipitation experiments to confirm direct interaction with regulatory proteins
Use ubiquitination assays to identify specific lysine residues targeted for degradation
Monitor protein levels under various cellular stress conditions
Studies have shown that DNA damage induces MASTL upregulation within hours post treatment with damaging agents like doxorubicin, hydroxyurea, or camptothecin . This upregulation correlates with activation of ATM/ATR signaling pathways. Conversely, E6AP depletion leads to increased MASTL protein levels without significant changes in mRNA expression, while overexpression of E6AP reduces MASTL protein levels . These findings demonstrate that MASTL stability is dynamically regulated during stress responses, which has important implications for its functions beyond basic cell cycle control.
For optimal expression of recombinant Ailuropoda melanoleuca MASTL, researchers should consider a systematic approach:
Construct Design Strategies:
Create multiple constructs with varying boundaries to address potential solubility issues
Include full-length MASTL and truncated versions that retain the cryptic C-lobe within the NCMR
Incorporate affinity tags (His, GST, MBP) with TEV protease cleavage sites
Consider codon optimization for the expression system of choice
Expression System Selection:
Bacterial systems (E. coli): Suitable for truncated constructs; use low temperature induction
Insect cell systems (Sf9/Hi5): Preferred for full-length protein; allows for some post-translational modifications
Mammalian systems (HEK293): Ideal for studies requiring native-like post-translational modifications
Purification Protocol:
Multi-step purification combining affinity chromatography with ion exchange and size exclusion
Include phosphatase inhibitors to preserve phosphorylation status
Verify protein integrity by mass spectrometry
Assess activity with in vitro kinase assays using ENSA/ARPP19 substrates
Quality Control Metrics:
SDS-PAGE and western blotting for purity assessment
Circular dichroism to confirm proper folding
Dynamic light scattering to assess homogeneity
Thermal shift assays to evaluate stability
For MASTL from Ailuropoda melanoleuca specifically, researchers should utilize the available giant panda genome sequence to design appropriate primers for gene amplification, considering the conservation of MASTL across mammalian species while accounting for potential species-specific variations.
To accurately measure MASTL kinase activity, researchers should employ complementary approaches:
Direct Kinase Activity Assays:
Radioactive assays: Incubate MASTL with [γ-32P]ATP and purified substrates (ENSA/ARPP19)
Non-radioactive alternatives: Use phospho-specific antibodies or phospho-sensors
Mass spectrometry: Identify and quantify specific phosphorylation sites
Reaction conditions: 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.1 mM ATP, 1 mM DTT at 30°C
Functional Readouts:
PP2A/B55 inhibition assays: Measure phosphatase activity toward model substrates
Cell-free systems: Use Xenopus egg extracts supplemented with recombinant MASTL
Cell-based reporters: Employ fluorescent reporters of PP2A/B55 activity
Kinetic Analysis:
| Parameter | Measurement Technique | Expected Range | Considerations |
|---|---|---|---|
| Kinase Activity | 32P incorporation | 5-50 pmol/min/μg | Ensure linear range |
| Substrate Affinity (Km) | Velocity vs. substrate concentration | 1-10 μM for ENSA/ARPP19 | Use multiple substrate concentrations |
| Activation Status | Phospho-specific antibodies | >80% activity requires phosphorylation | Monitor key regulatory sites |
| Inhibition (IC50) | Dose-response curves | 0.1-1 μM for GKI-1 | Include positive controls |
When working with recombinant Ailuropoda melanoleuca MASTL specifically, researchers should compare its enzymatic properties with well-characterized human MASTL to identify any species-specific differences in substrate preference, regulation, or inhibitor sensitivity.
To investigate MASTL's role in DNA damage response (DDR) pathways, researchers should implement a multi-faceted approach:
Cell-Based Damage Response Systems:
Treat cells with specific DNA damaging agents: doxorubicin, hydroxyurea, camptothecin, or ionizing radiation
Monitor MASTL protein levels at multiple time points (1-24 hours post-treatment)
Assess phosphorylation status of MASTL using phospho-specific antibodies
Correlate MASTL levels with activation of ATM/ATR signaling (phospho-ATM, phospho-CHK1/2)
Genetic Manipulation Approaches:
Pathway Analysis Techniques:
Evaluate phosphorylation status of key DDR proteins (γH2AX, 53BP1, RPA)
Assess cell cycle checkpoint activation (G2/M arrest)
Measure DNA repair capacity (comet assay, repair foci resolution)
Determine cell survival and apoptosis rates following damage
Mechanistic Investigations:
Research has demonstrated that DNA damage induces MASTL upregulation, consistent with ATM/ATR signaling activation . This regulation appears to be mediated in part through the E6AP ubiquitin ligase, which controls MASTL protein stability. Understanding this pathway has implications for cancer therapy, as MASTL inhibition can enhance sensitivity to DNA-damaging agents like cisplatin .
Phosphoproteomic analysis of MASTL activity requires rigorous methodological approaches for accurate interpretation:
Experimental Design Considerations:
Include appropriate controls (MASTL knockout, kinase-dead mutants, inhibitor treatment)
Design time-course experiments to capture dynamic changes
Use synchronized cell populations for cell cycle-specific analysis
Employ both targeted and discovery-based approaches
Data Processing Framework:
Normalize phosphopeptide abundances to protein levels to distinguish regulation by phosphorylation vs. expression
Apply appropriate statistical tests with multiple testing correction
Use clustering algorithms to identify co-regulated phosphosites
Perform motif analysis to identify potential direct MASTL substrates
Biological Interpretation Strategies:
Distinguish direct MASTL substrates from downstream effects
Classify substrates by cellular function and localization
Compare with known CDK1 substrates and PP2A/B55 targets
Integrate with protein-protein interaction networks
Validation Approaches:
Confirm key phosphosites with phospho-specific antibodies
Perform in vitro kinase assays with recombinant proteins
Generate phosphomimetic and phospho-deficient mutants
Assess functional consequences of site-specific mutations
Comparative analyses of MASTL across species provide valuable evolutionary insights through several methodological approaches:
Sequence-Based Analyses:
Perform multiple sequence alignments of MASTL from diverse species
Calculate evolutionary rates for different domains (N-lobe, C-lobe, NCMR)
Identify conserved functional motifs and species-specific variations
Construct phylogenetic trees to visualize evolutionary relationships
Structural Comparisons:
Map conservation patterns onto structural models
Identify structurally conserved regions despite sequence divergence
Compare the NCMR organization across species
Analyze the conservation of regulatory phosphorylation sites
Functional Conservation Assessment:
Compare substrate specificity across species (ENSA/ARPP19 phosphorylation)
Evaluate cross-species complementation in knockout systems
Assess conservation of protein-protein interactions
Compare regulatory mechanisms (activation, inhibition, localization)
| Species | MASTL Name | NCMR Length | Key Regulatory Features | Conservation Level |
|---|---|---|---|---|
| Human | MASTL | ~550 aa | CDK1 phosphorylation sites | Reference |
| Mouse | Mastl | ~545 aa | Similar to human | High |
| Xenopus | Greatwall | ~500 aa | Multiple mitotic phosphorylation sites | Moderate |
| Drosophila | Greatwall | ~400 aa | Required for mitosis | Moderate |
| S. cerevisiae | Rim15 | Variable | Nutrient-responsive regulation | Low |
| S. pombe | Ppk18 | Variable | Cell size control | Low |
| A. melanoleuca | MASTL | ~550 aa (predicted) | Presumed similar to other mammals | High (presumed) |
MASTL appears in different forms across species: Mastl in mammals, Greatwall in amphibians and insects, Rim15 in budding yeast, and Ppk18 in fission yeast . While the core kinase function in cell cycle regulation is conserved, the specific regulatory mechanisms and additional functions show variation. For instance, yeast orthologs also play roles in nutrient signaling . Understanding these evolutionary patterns can help identify the fundamental aspects of MASTL function versus species-specific adaptations.
When analyzing MASTL expression changes in disease contexts, researchers should employ systematic interpretative frameworks:
Expression Analysis Methodology:
Use multiple detection methods (qRT-PCR, western blot, immunohistochemistry)
Compare mRNA with protein levels to identify post-transcriptional regulation
Assess phosphorylation status alongside total protein levels
Evaluate subcellular localization patterns
Clinical Correlation Approaches:
Correlate MASTL expression with disease progression and patient outcomes
Compare across disease subtypes and stages
Assess relationship with established biomarkers
Evaluate potential as a prognostic or predictive biomarker
Mechanistic Interpretation Framework:
Analyze entire MASTL-ENSA/ARPP19-PP2A/B55 pathway components
Assess correlation with cell cycle markers and chromosome stability
Evaluate relationship with DNA damage response efficiency
Consider connections to treatment resistance mechanisms
Therapeutic Implication Assessment:
Determine potential for MASTL-targeted interventions
Evaluate synergies with existing therapies
Identify patient subgroups likely to benefit from MASTL inhibition
Consider resistance mechanisms to MASTL-directed therapies
Research has shown that MASTL upregulation is common in multiple types of cancer, including oral squamous cell carcinoma (OSCC), and is associated with aggressive clinicopathological features . In OSCC specifically, upregulation of MASTL and ENSA/ARPP19, coupled with downregulation of PP2A/B55, correlates with cisplatin resistance and poor patient survival . MASTL inhibition with GKI-1 enhances cisplatin sensitivity in cancer cells, suggesting therapeutic potential. These findings indicate that MASTL expression changes should be interpreted in the context of the entire pathway and may have important implications for treatment selection and development of combination therapies.
Advanced structural biology methods offer powerful insights into MASTL function through several methodological approaches:
X-ray Crystallography and Cryo-EM Strategies:
Crystallize functionally relevant MASTL domains separately
Focus on the unique NCMR region and cryptic C-lobe
Capture different conformational states (active/inactive)
Co-crystallize with substrates, ATP analogs, or inhibitors
Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS) Applications:
Map protein dynamics across different regions
Identify structural changes upon activation
Delineate binding interfaces with interacting partners
Assess conformational changes induced by phosphorylation
Computational Structural Biology Methods:
Perform molecular dynamics simulations to understand flexibility
Use homology modeling for regions lacking experimental structures
Apply docking studies to predict substrate and inhibitor binding
Implement molecular modeling to understand the NCMR organization
Integrative Structural Biology Approach:
Combine multiple techniques (SAXS, NMR, cross-linking MS)
Generate comprehensive structural models
Correlate structural features with functional data
Design structure-guided mutations to test hypotheses
HDX-MS analysis has revealed that the C-lobe in full-length MASTL forms a stable structure, whereas the N-lobe is more dynamic . The NCMR and C-tail contain few localized regions with higher-order structure. This structural information helps explain how truncated versions of MASTL containing the cryptic C-lobe can maintain catalytic activity .
Understanding the structural basis for MASTL function can facilitate the design of specific inhibitors and provide insights into how disease-associated mutations affect enzyme function. For Ailuropoda melanoleuca MASTL specifically, comparative structural analysis with human MASTL could reveal species-specific adaptations that might inform evolutionary biology and potentially conservation medicine.
Developing selective MASTL inhibitors requires integrated methodological approaches:
High-Throughput Screening Strategies:
Design activity-based assays using recombinant MASTL and fluorescent substrates
Implement thermal shift assays for compound binding assessment
Utilize fragment-based screening to identify chemical starting points
Develop cell-based phenotypic screens monitoring PP2A/B55 activity
Structure-Guided Design Methods:
Target unique features of MASTL, particularly the ATP-binding pocket
Exploit structural differences between MASTL and related kinases
Design allosteric inhibitors targeting NCMR-mediated regulation
Use molecular docking to predict binding modes and guide optimization
Medicinal Chemistry Optimization Framework:
Establish structure-activity relationships (SAR)
Optimize for potency, selectivity, and pharmacokinetic properties
Address potential resistance mechanisms
Balance efficacy with toxicity profile
Validation Approaches:
Test inhibitors against panels of kinases to confirm selectivity
Utilize MASTL knockout cells as negative controls
Assess on-target engagement in cells using cellular thermal shift assays
Verify mechanism of action through phosphoproteomic profiling
GKI-1 represents the first-in-class small molecule inhibitor of MASTL kinase and has shown promising efficacy in enhancing cisplatin sensitivity in OSCC cells . Importantly, GKI-1 exhibited anti-cancer effects at doses substantially lower than those needed to disrupt mitotic entry, suggesting a therapeutic window that exploits non-mitotic functions of MASTL .
| Inhibitor Property | Testing Methodology | Desired Characteristics | Challenges |
|---|---|---|---|
| Potency (IC50) | In vitro kinase assays | <100 nM | Maintaining activity in cellular context |
| Selectivity | Kinase panel screening | >100-fold vs. related kinases | Highly conserved ATP-binding sites |
| Cell Permeability | Cellular target engagement | Active at 0.1-1 μM in cells | Balancing potency with physicochemical properties |
| In vivo Efficacy | Xenograft models | Enhanced chemosensitivity | Developing suitable formulations |
Developing selective MASTL inhibitors has significant therapeutic potential, particularly for combination therapies with DNA-damaging agents in cancers where MASTL is upregulated.
Systems biology approaches offer comprehensive frameworks for understanding MASTL's role within cellular networks:
Network Reconstruction Methods:
Perform protein-protein interaction screens (Y2H, AP-MS, BioID)
Integrate phosphoproteomic data to map kinase-substrate relationships
Construct signaling pathway models incorporating MASTL, ENSA/ARPP19, and PP2A/B55
Identify feedback and feedforward loops in the network
Dynamic Modeling Approaches:
Multi-omics Integration Strategies:
Combine transcriptomic, proteomic, and phosphoproteomic data
Correlate MASTL activity with global cellular state changes
Identify emergent properties from pathway interactions
Map MASTL-dependent processes across cell cycle phases
Perturbation Biology Framework:
Systematically perturb network components (genetic knockdowns, inhibitors)
Measure global responses using high-content screening
Identify synthetic lethal interactions with MASTL inhibition
Discover context-dependent functions across cell types
Research has established several key network connections for MASTL:
The MASTL-ENSA/ARPP19-PP2A/B55 pathway regulates mitotic progression
The ATM-E6AP-MASTL axis mediates DNA damage checkpoint responses
MASTL modulates cisplatin resistance in cancer cells through effects on DNA damage accumulation
Connections exist between MASTL and nutrient sensing pathways
By integrating these pathways into comprehensive network models, researchers can generate testable hypotheses about MASTL function in normal physiology and disease states. For Ailuropoda melanoleuca MASTL specifically, comparative network analysis with human MASTL could reveal species-specific adaptations in regulatory networks.
MASTL research in conservation biology, particularly for the giant panda (Ailuropoda melanoleuca), presents several promising directions:
Reproductive Biology Applications:
Investigate MASTL's role in gamete formation and early embryonic development
Assess MASTL expression and function in reproductive tissues
Explore potential implications for assisted reproductive technologies
Correlate MASTL variants with reproductive success in breeding programs
Population Genetics Approach:
Sequence MASTL across wild and captive panda populations
Identify functional polymorphisms and their distribution
Assess genetic diversity in regulatory regions affecting MASTL expression
Evaluate potential adaptive significance of MASTL variants
Environmental Stress Response Studies:
Examine how environmental factors affect MASTL function
Investigate MASTL's role in cellular responses to habitat-related stressors
Assess potential impacts of climate change on MASTL-dependent processes
Develop ex vivo models to study environmental influences
Comparative Biology Framework:
Compare MASTL across related species with different conservation statuses
Correlate MASTL function with life history traits and reproductive strategies
Investigate MASTL in the context of species-specific adaptations
Use findings to inform broader conservation strategies
Beyond its established role in mitosis, several non-mitotic functions of MASTL deserve deeper investigation:
DNA Damage Response Pathway:
Transcriptional Regulation Mechanisms:
Examine potential interactions with transcription factors
Investigate effects on chromatin remodeling complexes
Assess MASTL-dependent gene expression programs
Explore nuclear vs. cytoplasmic functions of MASTL
Metabolism and Nutrient Sensing:
Cytoskeletal Regulation:
Examine MASTL's interaction with microtubule networks
Investigate roles in cell migration and invasion
Assess contributions to cellular mechanical properties
Explore functions in specialized cell types (neurons, immune cells)
Research has already revealed MASTL's involvement in DNA replication through ENSA, coordination during recovery from DNA damage, and a possible function in regulating actin and cytoskeleton . MASTL upregulation correlates with cisplatin resistance in cancer, suggesting roles beyond mitotic control . The MASTL ortholog in yeast (Rim15) responds to nutrient conditions, indicating potential metabolic functions .
These emerging non-mitotic functions may be particularly relevant for understanding MASTL's role in specialized cell types and stress responses, which could have implications for both basic science and applied research in fields like conservation biology and medicine.
MASTL research offers a unique lens for examining species-specific cellular adaptations through several methodological approaches:
Comparative Functional Genomics:
Compare MASTL sequence, expression, and regulation across species
Identify species-specific variations in the NCMR region
Correlate MASTL features with species' physiological traits
Investigate adaptive mutations in different environmental contexts
Species-Specific Cell Cycle Regulation:
Examine differences in cell cycle control across species
Compare MASTL-dependent checkpoints in different organisms
Assess variation in PP2A/B55 regulation mechanisms
Relate findings to species' regenerative capabilities and lifespan
Environmental Adaptation Analysis:
Study how MASTL function varies with species' habitat and environmental challenges
Investigate temperature-dependent regulation across species
Examine MASTL's role in hibernation or torpor in relevant species
Explore adaptations to specific environmental stressors
Evolutionary Medicine Applications:
Identify species-specific differences in disease susceptibility related to MASTL
Compare MASTL's role in cancer across species with varying cancer rates
Investigate MASTL in longevity-associated pathways across species
Apply insights to develop improved models for human disease
The giant panda (Ailuropoda melanoleuca) represents an interesting case study due to its unique evolutionary history, specialized diet, and conservation challenges . By comparing MASTL function between giant pandas and closely related species, researchers could gain insights into cellular adaptations related to the panda's distinctive life history traits. These comparative studies might reveal how fundamental cell cycle regulators like MASTL have been fine-tuned through evolution to support species-specific physiological requirements.